.

Prof. Dr. Robin Wilkening

Professur für vergleichende Gesundheitswissenschaften an der EU|FH Rostock

Prof. Dr. Robin Wilkening

Kontaktieren Sie mich

Prof. Dr. Robin Wilkening
Professur für vergleichende Gesundheitswissenschaften

Prof. Dr. Robin Wilkening

Studiengänge

  • Gesundheitsforschung und Therapiewissenschaften (M.Sc.)
  • Physician Assistance (M.Sc.)

ORCID iD 0000-0002-8332-5016

Profil Profil
Externe Aktivitäten Externe Aktivitäten
Publikationen Publikationen

Profil

2020-2023
Vize-Präsident Postgraduales Studium & Qualität
Europäische Fachhochschule (EU|FH), Rostock

 

2018-2020
Dekan – Europäische Fachhochschule (EU|FH),
Fachbereich Angewandte Gesundheitswissenschaften

 

Seit 2016
Gastprofessur „Adjunct Professor“
Monash University, School of Public Health & Preventive Medicine, Melbourne

 

Seit 2014
Professur „Gesundheitswissenschaften“
Europäische Fachhochschule (EU|FH), Rostock

 

2013-2014
Leitung Biobank
Universitätsmedizin Greifswald
Institut für klinische Chemie & Laboratoriumsmedizin

 

2013
Universitätsmedizin Greifswald
Habilitation Epidemiologie

 

2010-2011
Boston University
Post-Doc Framingham Heart Study

 

2007-2010
Universitätsmedizin Greifswald
Promotion Epidemiologie (summa cum laude)

 

2002-2006
Universität Rostock
Diplom Demographie

Externe Aktivitäten

Seit 2023
Referent für Gesundheitspolitik
Fraktion Bündnis90/Die Grünen im Landtag Mecklenburg-Vorpommern
2. Parlamentarischer Untersuchungsausschuss „Universitätsmedizin“

Publikationen

Veröffentlichungen

Lehrbücher (Hrsg.)
Gesundheitswissenschaften, 2. Aufl., Springer, Heidelberg (989 S.)
Handbook of Global Health, Springer, New York (2.948 S.)

Fachpublikationen
>100 peer-reviewed original publications | siehe: ORCID 0000-0002-8332-5016

Sachbücher
Buchautor zu den Themen Gesundheit & Nachhaltigkeit bei Ullstein, C.H.Beck u.a.

 

Publikationen
*geb: Haring

88. Balzer J, Jung A, Gerhard J, Reinecke S, Mijic M, Fichtmüller A, Jahjha A, Eggert M, Koch M, Ernst K, Haring R. Psychometric properties of questionnaires to assess evidence-based practice amongoccupational, physical and speech therapists: A systematic review. The Journal of Evidence and Qualityin Health Care. 2023. doi.org/10.1016/j.zefq.2022.11.003.

87. Kische H, Pieper L, Voss C, Ollmann TM, Haring R, Rückert F, Beesdo-Baum, K. Hair androgenconcentrations and depressive disorders in adolescents from the general population. European Child &Adolescent Psychiatry. 2022. doi: 10.1007/s00787-021-01929-w.

86. Yeap B.B., Marriott R.J., Antonio L., Raj S., Dwivedi G., Reid C.M., Anawalt B.D., Bhasin S., Dobs A.S.,Handelsman D.J., Hankey G.J., Haring R., Matsumoto A.M., Norman P.E., O’Neill T.W., Ohlsson C., OrwollE.S., Vanderschueren D., Wittert G.A., Wu F.C.W., Murray K. Associations of serum testosterone and sexhormone-binding globulin with incident cardiovascular events in middle-aged to older men. Ann InternMed. 2022 Feb;175(2):159-170.

85. Marriott R.J., Murray K., Flicker L., Hankey G.J., Matsumoto A.M., Dwivedi G., Antonio L., AlmeidaO.P., Bhasin S., Dobs A.S., Handelsman D.J., Haring R., O’Neill T.W., Ohlsson C., Orwoll E.S., Vanderschueren D., Wittert G.A., Wu F.C.W., Yeap B.B. Lower serum testosterone concentrations areassociated with higher incidence of dementia in men: the UK Biobank prospective cohort study.Alzheimer’s & Dementia. 2022 Oct;18(10):1907-1918.

84. Bell R, Haring R. When you are making plans to publish research, you need to plan for data sharing.Climacteric. 2020 Oct;23(5):466-467.

83. Haring R , Ghannad M, Bertizzolo L, Page M. No evidence found for an association between trialcharacteristics and treatment effects in randomized trials of testosterone therapy in men: a meta-epidemiological study. J Clin Epi. 2020;(122):12-19.

82. Asselmann E, Kische H, Haring R, Hertel J, Schmidt CO, Nauck M, Beesdo-Baum K, Grabe HJ, Pané-Farré CA. Prospective associations of androgens and sex hormone-binding globulin with 12-month,lifetime and incident anxiety and depressive disorders in men and women from the general population. JAffect Disord. 2019; Feb 15;245:905-911.

81. Kische H. Hoyer J, Pieper L, Venz J, Klotsche J, März W, Koch-Gromus U, Pittrow D, Lehnert H, SilberS, Stalla GK, Zeiher AM, Wittchen HU, Haring R. Testosterone is not associated with traits of optimismor pessimism: Observational evidence from the prospective DETECT study. PLoS One. 2018 Nov29;13(11):e0207870.

80. Haring R. Does testosterone shorten life? Triangulation of a much-debated association.BMJEvidence-Based Medicine. 2018 Jun, 23 (Suppl 1) A26; doi: 10.1136/bmjebm-2018-111024.52.

79. Haring R, Bell R. Lack of research reproducibility, open science and continuing education in researchmethods. Climacteric. 2018 Oct;21(5):413-414.

78. Seyfart T, Friedrich F, Kische H, Wallaschofski H, Völzke H, Nauck M, Keevil BG, Haring R. Associationof sex hormones with physical, laboratory, and imaging markers of anthropometry in men and womenfrom the general population. PLoS One. 2018; 13(1):e0189042.

77. Kische H, Pieper L, Venz J, Klotsche J, März W, Koch-Gromus U, Pittrow D, Lehnert H, Silber S, StallaGK, Zeiher AM, Wittchen HU, Haring R. Longitudinal change instead of baseline testosterone predictsdepressive symptoms. Psychoneuroendocrinology. 2017;89:7-12.

76. Haring R. Meta-epidemiology of testosterone’s risks and benefits: will we ever know the answer?JAMA Intern Med. 2017;177(9):1392.

75. Pätzug K, Friedrich N, Kische H, Hannemann A, Völzke H, Nauck M, Keevil BG, Haring R. Sexhormones and quantitative ultrasound parameters at the heel in men and women from the generalpopulation. Bone Reports. 2017;7:51-6.

74. Kische H, Gross S, Wallaschofski H, Grabe HJ, Völzke H, Nauck M, Haring R. Associations ofandrogens with depressive symptoms and cognitive status in the general population. PLoS One.2017;12(5):e0177272.

73. Eriksson J, Haring R, Grarup N, Vandenput L, Wallaschofski H, Lorentzen E, Hansen T, Mellström D,Pedersen O, Nauck M, Lorentzon M, Nystrup Husemoen LL, Völzke H, Karlsson M, Baumeister SE,Linneberg A, Ohlsson C. Causal relationship between obesity and serum testosterone status in men: Abi-directional mendelian randomization analysis. PLoS One. 2017;12(4):e0176277.

72. Kische H, Arnold A, Gross S, Wallaschofski H, Völzke H, Nauck M, Haring R. Sex hormones and hairloss in men from the general population of Northeastern Germany. JAMA Dermatol. 2017;153(9):935-937.

71. Kische H, Gross S, Wallaschofski H, Völzke H, Dörr M, Nauck M, Haring R. Clinical correlates of sexhormones in women: The study of health in Pomerania. Metabolism. 2016;65:1286-96.

70. Kische H, Ewert R, Fietze I, Gross S, Wallaschofski H, Völzke H, Dörr M, Nauck M, Obst A, Stubbe B,Penzel T, Haring R. Sex hormones and sleep in men and women from the general population: a cross-sectional observational study. J Clin Endocrinol Metab. 2016;101(11):3968-77.

69. Haring R, Enserro D, Xanthakis V, Mitchell GF, Benjamin EJ, Hamburg NM, Sullivan L, Nauck M,Wallaschofski H, Vasan RS. Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association WithCardiovascular Disease and Mortality in the Framingham Heart Study. J Am Heart Assoc. 2016;5(7).

68. Haring R, Wallaschofski H, Völzke H, Flessa S, Keevil BG, Nauck M, Baumeister SE. Associations ofandrogens with health care utilization and costs in women-Perspectives of a population-based cohortstudy. Maturitas. 2016;89:5-8.

67 .Kische H, Gross S, Wallaschofski H, Völzke H, Dörr M, Nauck M, Felix SB, Haring R. Serum androgenconcentrations and subclinical measures of cardiovascular disease in men and women. Atherosclerosis.2016;247:193-200.

66. Lu Y, Day FR, Gustafsson S, Buchkovich ML, Na J, Bataille V, Cousminer DL, Dastani Z, Drong AW,Esko T, Evans DM, Falchi M, Feitosa MF, Ferreira T, Hedman ÅK, Haring R, Hysi PG, Iles MM, Justice AE,Kanoni S, Lagou V, Li R, Li X, Locke A, Lu C, Mägi R, Perry JR, Pers TH, Qi Q, Sanna M, Schmidt EM, ScottWR, Shungin D, Teumer A, Vinkhuyzen AA, Walker RW, Westra HJ, Zhang M, Zhang W, Zhao JH, Zhu Z,Afzal U, Ahluwalia TS, Bakker SJ, Bellis C, Bonnefond A, Borodulin K, Buchman AS, Cederholm T, ChohAC, Choi HJ, Curran JE, de Groot LC, De Jager PL, Dhonukshe-Rutten RA, Enneman AW, Eury E, EvansDS, Forsen T, Friedrich N, Fumeron F, Garcia ME, Gärtner S, Han BG, Havulinna AS, Hillege H, IttermannT, Kent JW, Kolcic I, Laatikainen T, Lahti J, Mateo Leach I, Lee CG, Lee JY, Liu T, Liu Y, Lobbens S, Loh M,Lyytikäinen LP, Medina-Gomez C, Michaëlsson K, Nalls MA, Nielson CM, Oozageer L, Pascoe L,Paternoster L, Polašek O, Ripatti S, Sarzynski MA, Shin CS, Narančić NS, Spira D, Srikanth P, Steinhagen-Thiessen E, Sung YJ, Swart KM, Taittonen L, Tanaka T, Tikkanen E, van der Velde N, van Schoor NM,Verweij N, Wright AF, Yu L, Zmuda JM, Eklund N, Forrester T, Grarup N, Jackson AU, Kristiansson K,Kuulasmaa T, Kuusisto J, Lichtner P, Luan J, Mahajan A, Männistö S, Palmer CD, Ried JS, Mangino M,Mcknight B, Menni C, O’Connell JR, Oostra BA, Shuldiner AR, Song K, Vandenput L, van Duijn CM,Vollenweider P, White CC, Boehnke M, Boettcher Y, Cooper RS, Forouhi NG, Gieger C, Grallert H,Hingorani A, Jørgensen T, Jousilahti P, Kivimaki M, Kumari M, Laakso M, Langenberg C, Linneberg A,Luke A, Mckenzie CA, Palotie A, Pedersen O, Peters A, Strauch K, Tayo BO, Wareham NJ, Bennett DA,Bertram L, Blangero J, Blüher M, Bouchard C, Campbell H, Cho NH, Cummings SR, Czerwinski SA,Demuth I, Eckardt R, Eriksson JG, Ferrucci L, Franco OH, Froguel P, Gansevoort RT, Hansen T, Harris TB,Hastie N, Heliövaara M, Hofman A, Jordan JM, Jula A, Kähönen M, Kajantie E, Knekt PB, Koskinen S,Kovacs P, Lehtimäki T, Lind L, Liu Y, Orwoll ES, Osmond C, Perola M, Pérusse L, Raitakari OT, RankinenT, Rao DC, Rice TK, Rivadeneira F, Rudan I, Salomaa V, Sørensen TI, Stumvoll M, Tönjes A, Towne B,Tranah GJ, Tremblay A, Uitterlinden AG, van der Harst P, Vartiainen E, Viikari JS, Vitart V, Vohl MC,Völzke H, Walker M, Wallaschofski H, Wild S, Wilson JF, Yengo L, Bishop DT, Borecki IB, Chambers JC,Cupples LA, Dehghan A, Deloukas P, Fatemifar G, Fox C, Furey TS, Franke L, Han J, Hunter DJ,Karjalainen J, Karpe F, Kaplan RC, Kooner JS, McCarthy MI, Murabito JM, Morris AP, Bishop JA, North KE,Ohlsson C, Ong KK, Prokopenko I, Richards JB, Schadt EE, Spector TD, Widén E, Willer CJ, Yang J,Ingelsson E, Mohlke KL, Hirschhorn JN, Pospisilik JA, Zillikens MC, Lindgren C, Kilpeläinen TO, Loos RJ.New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. NatCommun. 2016;7:10495.

65. Fenske B, Kische H, Gross S, Wallaschofski H, Völzke H, Dörr M, Nauck M, Keevil BG, Brabant G, Haring R. Endogenous androgens and sex hormone-binding globulin in women and risk of metabolicsyndrome and type 2 diabetes. J Clin Endocrinol Metab. 2015;100(12):4595-603.

64. Schaffrath G, Kische H, Gross S, Wallaschofski H, Völzke H, Dörr M, Nauck M, Keevil BG, Brabant G, Haring R. Association of sex hormones with incident 10-year cardiovascular disease and mortality inwomen. Maturitas. 2015;82(4):424-30.

63. Haring R, Schurmann C, Homuth G, Steil L, Völker U, Völzke H, Keevil BG, Nauck M, Wallaschofski H.Associations between serum sex hormone concentrations and whole blood gene expression profiles inthe general population. PLoS One. 2015;10(5):e0127466.

62. Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, Hultcrantz R, Hagström H,Yoon SK, Charatcharoenwitthaya P, George J, Barrera F, Hafliðadóttir S, Björnsson ES, Armstrong MJ,Hopkins LJ, Gao X, Francque S, Verrijken A, Yilmaz Y, Lindor KD, Charlton M,
Haring R, Lerch MM, RettigR, Völzke H, Ryu S, Li G, Wong LL, Machado M, Cortez-Pinto H, Yasui K, Cassader M. Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis. PLoSMed. 2014;11(7):e1001680.

61. JS Brand, MM Rovers, HJ Schneider, TP Tuomainen, BB Yeap, SAP Chubb, OP Almeida, R Haring, GCorona, A Onat, L Ferrucci, M Maggio, PCY Tong, RYT Chen, M Akishita, JA Gietema, MH Gannagé-Yared,NP Goncharov, P Kumanov, AL Undén, C Bouchard, A. Hautanen and YT van der Schouw. Testosterone,sex hormone-binding globulin and the metabolic syndrome in men: An individual participant data meta-analysis of observational studies. PLoS One. 2014;9(7):e100409.

60. Perry JR, Day F, Elks CE, Sulem P, Thompson DJ, Ferreira T, He C, Chasman DI, Esko T, ThorleifssonG, Albrecht E, Ang WQ, Corre T, Cousminer DL, Feenstra B, Franceschini N, Ganna A, Johnson AD,Kjellqvist S, Lunetta KL, McMahon G, Nolte IM, Paternoster L, Porcu E, Smith AV, Stolk L, Teumer A,Tšernikova N, Tikkanen E, Ulivi S, Wagner EK, Amin N, Bierut LJ, Byrne EM, Hottenga JJ, Koller DL,Mangino M, Pers TH, Yerges-Armstrong LM, Hua Zhao J, Andrulis IL, Anton-Culver H, Atsma F, BandinelliS, Beckmann MW, Benitez J, Blomqvist C, Bojesen SE, Bolla MK4, Bonanni B, Brauch H, Brenner H, BuringJE, Chang-Claude J, Chanock S, Chen J, Chenevix-Trench G, Collée JM, Couch FJ, Couper D, Coviello AD,Cox A, Czene K, D’adamo AP, Davey Smith G, De Vivo I, Demerath EW, Dennis J, Devilee P, DieffenbachAK, Dunning AM, Eiriksdottir G, Eriksson JG, Fasching PA, Ferrucci L, Flesch-Janys D, Flyger H, Foroud T,Franke L, Garcia ME, García-Closas M, Geller F, de Geus EE, Giles GG, Gudbjartsson DF, Gudnason V,Guénel P, Guo S, Hall P, Hamann U, Haring R, Hartman CA, Heath AC, Hofman A, Hooning MJ, Hopper JL,Hu FB, Hunter DJ, Karasik D, Kiel DP, Knight JA, Kosma VM, Kutalik Z, Lai S, Lambrechts D, Lindblom A,Mägi R, Magnusson PK, Mannermaa A, Martin NG, Masson G, McArdle PF, McArdle WL, Melbye M,Michailidou K, Mihailov E, Milani L, Milne RL, Nevanlinna H, Neven P, Nohr EA, Oldehinkel AJ, Oostra BA,Palotie A, Peacock M, Pedersen NL, Peterlongo P, Peto J, Pharoah PD, Postma DS, Pouta A, Pylkäs K,Radice P, Ring S, Rivadeneira F, Robino A, Rose LM, Rudolph A, Salomaa V, Sanna S, Schlessinger D,Schmidt MK, Southey MC, Sovio U, Stampfer MJ, Stöckl D, Storniolo AM, Timpson NJ, Tyrer J, Visser JA,Vollenweider P, Völzke H, Waeber G, Waldenberger M, Wallaschofski H, Wang Q, Willemsen G, WinqvistR, Wolffenbuttel BH, Wright MJ; Australian Ovarian Cancer Study; GENICA Network; kConFab; LifeLinesCohort Study; InterAct Consortium; Early Growth Genetics (EGG) Consortium, Boomsma DI, Econs MJ,Khaw KT, Loos RJ, McCarthy MI, Montgomery GW, Rice JP, Streeten EA, Thorsteinsdottir U, van DuijnCM, Alizadeh BZ, Bergmann S, Boerwinkle E, Boyd HA, Crisponi L, Gasparini P, Gieger C, Harris TB,Ingelsson E, Järvelin MR, Kraft P, Lawlor D, Metspalu A, Pennell CE, Ridker PM, Snieder H, Sørensen TI,Spector TD, Strachan DP, Uitterlinden AG, Wareham NJ38, Widen E, Zygmunt M, Murray A, Easton DF,Stefansson K, Murabito JM, Ong KK. Parent-of-origin specific allelic associations among 106 genomicloci for age at menarche. Nature. 2014;514(7520):92-7.

59. Haring R, Baumeister SE, Dörr M, Felix SB, Völzke H, Spielhagen C, Lüdemann J, Nauck M,Wallaschofski H. Glycated hemoglobin as a marker of subclinical atherosclerosis and cardiac remodelingamong non-diabetic adults from the general population. Diabetes Res Clin Pract. 2014;105(3):416-23.

58. Grabe HJ, Assel H, Bahls T, Dörr M, Endlich K, Endlich N, Erdmann P, Ewert R, Felix SB, Fiene B,Fischer T, Flessa S, Friedrich N, Gadebusch-Bondio M, Salazar MG, Hammer E, Haring R, Havemann C,Hecker M, Hoffmann W, Holtfreter B, Kacprowski T, Klein K, Kocher T, Kock H, Krafczyk J, Kuhn J,Langanke M, Lendeckel U, Lerch MM, Lieb W, Lorbeer R, Mayerle J, Meissner K, zu Schwabedissen HM,Nauck M, Ott K, Rathmann W, Rettig R, Richardt C, Saljé K, Schminke U, Schulz A, Schwab M, SiegmundW, Stracke S, Suhre K, Ueffing M, Ungerer S, Völker U, Völzke H, Wallaschofski H, Werner V, ZygmuntMT, Kroemer HK. Cohort profile: Greifswald approach to individualized medicine (GANI_MED). J TranslMed. 2014;12:144.

57. Moayyeri A, Hsu YH, Karasik D, Estrada K, Xiao SM, Nielson C, Srikanth P, Giroux S, Wilson SG, ZhengHF, Smith AV, Pye SR, Leo PJ, Teumer A, Hwang JY, Ohlsson C, McGuigan F, Minster RL, Hayward C,Olmos JM, Lyytikäinen LP, Lewis JR, Swart KM, Masi L, Oldmeadow C, Holliday EG, Cheng S, van SchoorNM, Harvey NC, Kruk M, Fabiola Del Greco M, Igl W, Trummer O, Grigoriou E, Luben R, Liu CT, Zhou Y,Oei L, Medina-Gomez C, Zmuda J, Tranah G, Brown SJ, Williams FM, Soranzo N, Jakobsdottir J,Siggeirsdottir K, Holliday KL, Hannemann A, Go MJ, Garcia M, Polasek O, Laaksonen M, Zhu K, EnnemanAW, McEvoy M, Peel R, Sham PC, Jaworski M, Johansson A, Hicks AA, Pludowski P, Scott R, Dhonukshe-Rutten RA, van der Velde N, Kähönen M, Viikari JS, Sievänen H, Raitakari OT, González-Macías J,Hernández JL, Mellström D, Ljunggren O, Cho YS, Völker U, Nauck M, Homuth G, Völzke H, Haring R,Brown MA, McCloskey E, Nicholson GC, Eastell R, Eisman JA, Jones G, Reid IR, Dennison EM, Wark J,Boonen S, Vanderschueren D, Wu FC, Aspelund T, Richards JB, Bauer D, Hofman A, Khaw KT, DedoussisG, Obermayer-Pietsch B, Gyllensten U, Pramstaller PP, Lorenc RS, Cooper C, Kung AW, Lips P, Alen M,Attia J, Brandi ML, de Groot LC, Lehtimäki T, Riancho JA, Campbell H, Liu Y, Harris TB, Akesson K,Karlsson M, Lee JY, Wallaschofski H, Duncan EL, O’Neill TW, Gudnason V, Spector TD, Rousseau F,Orwoll E, Cummings S, Wareham NJ, Rivadeneira F, Uitterlinden AG, Prince RL, Kiel DP, Reeve J, KaptogeSK. Genetic determinants of heel bone properties: Genome-wide association meta-analysis andreplication in the GEFOS/GENOMOS consortium. Hum Mol Genet. 2014;23(11):3054-68.

56. Haring R, Baumeister SE, Nauck M, Völzke H, Keevil BG, Brabant G, Wallaschofski H. Testosteroneand cardiometabolic risk in the general population – the impact of measurement method on riskassociations: a comparative study between immunoassay and mass spectrometry. Eur J Endocrinol.2013;169(4):463-70.

55. van der Loos MJHM, Haring R, Rietveld CA, Baumeister SE, Groenen PJF, Hofman A, de Jong FH,Koellinger PD, Kohlmann T, Nauck M, Rivadeneira F, Uitterlinden AG, van Rooij FJA, Wallaschofski H,Thurik AR. Serum testosterone levels in males are not associated with entrepreneurial behavior in twoindependent observational studies. sPhysiol Behav. 2013;119:110-4.

54. Ziemens B, Wallaschofski H, Völzke H, Rettig R, Dörr M, Nauck M, Keevil BG, Brabant G,Haring R.Positive association between testosterone, blood pressure, and hypertension in women. J Hypertens.2013;31(6):1106-13.

53. Balbach L, Wallaschofski H, Völzke H, Nauck M, Dörr M,
Haring R. Serum prolactin concentrations asrisk factor of metabolic syndrome or type 2 diabetes? BMC Endocrine Disorders. 2013;13:12.

52. Haring R, Wallaschofski H, Teumer A, Kroemer H, Taylor AE, Shackleton CHL, Nauck M, Völker U,Homuth G, Arlt W. A SULT2A1 genetic variant identified by GWAS as associated with low serum DHEASdoes not impact on the actual DHEA/DHEAS ratio. J Mol Endocrinol. 2012;50(1):73-7.

51. Hannemann A, Breer S, Wallaschofski H, Nauck M, Bode NWF, Baumeister SE, Barvencik F, Amling M,Schinke T,
Haring R, Keller J. Osteocalcin is Associated with Testosterone in the General Population andSelected Patients with Bone Disorders. Andrology. 2013;1(3):469-74.

50. Haring R, John U, Völzke H, Nauck M, Felix SB, Wallaschofski H. Low testosterone concentrations inmen contribute to the gender gap in cardiovascular morbidity and mortality. Gend Med. 2012;9(6):557-68.

49. Haring R, Teumer A, Völker U, Dörr M, Nauck M, Biffar R, Völzke H, Baumeister SE, Wallaschofski H.Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic riskfactors and mortality. Andrology. 2013;1(1):17-23.

48. Haring R, Teng Z, Xanthakis V, Coviello A, Sullivan L, Bhasin S, Murabito JM, Wallaschofski H, VasanRS. Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovasculardisease and all-cause mortality in elderly men from the Framingham Heart Study. Clin Endocrinol. 2013;(4)78:629–634.

47. Haring R, Friedrich N, Völzke H, Vasan RS, Felix SB, Dörr M, Meyer Zu Schwabedissen HE, Nauck M,Wallaschofski H. Positive association of serum prolactin concentrations with all-cause andcardiovascular mortality. Eur Heart J. 2014;35(18):1215-21.

46. Coviello AD, Haring R, Wellons M, Vaidya D, Lehtimäki T, Keildson S, Lunetta KL, He C, Fornage M,Lagou V, Mangino M, Onland-Moret NC, Chen B, Eriksson J, Garcia M, Liu YM, Koster A, Lohman K,Lyytikäinen LP, Petersen AK, Prescott J, Stolk L, Vandenput L, Wood AR, Zhuang WV, Ruokonen A,Hartikainen AL, Pouta A, Bandinelli S, Biffar R, Brabant G, Cox DG, Chen Y, Cummings S, Ferrucci L,Gunter MJ,
Hankinson SE, Martikainen H, Hofman A, Homuth G, Illig T, Jansson JO, Johnson AD, KarasikD, Karlsson M, Kettunen J, Kiel DP, Kraft P, Liu J, Ljunggren O, Lorentzon M, Maggio M, Markus MR,Mellström D, Miljkovic I, Mirel D, Nelson S, Morin Papunen L, Peeters PH, Prokopenko I, Raffel L, ReinckeM, Reiner AP, Rexrode K, Rivadeneira F, Schwartz SM, Siscovick D, Soranzo N, Stöckl D, Tworoger S,Uitterlinden AG, van Gils CH, Vasan RS, Wichmann HE, Zhai G, Bhasin S, Bidlingmaier M, Chanock SJ, DeVivo I, Harris TB, Hunter DJ, Kähönen M, Liu S, Ouyang P, Spector TD, van der Schouw YT, Viikari J,Wallaschofski H, McCarthy MI, Frayling TM, Murray A, Franks S, Järvelin MR, de Jong FH, Raitakari O,Teumer A, Ohlsson C, Murabito JM, Perry JR. A genome-wide association meta-analysis of circulating sexhormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoSGenet. 2012;8(7):e1002805.

45. Haring R, Rosvall M, Völker U, Völzke H, Kroemer H, Nauck M, Wallaschofski H. A network-basedapproach to visualize prevalence and progression of metabolic syndrome components. PLoS One.2012;7(6):e39461.

44. Haring R, Völzke H, Spielhagen C, Nauck M, Wallaschofski H. The role of sex hormone-bindingglobulin and testosterone in the risk of incident metabolic syndrome. Eur J Prev Cardiol. 2013;20(6):1061-8.

43. Haring R, Perspectives for metabolomics in testosterone replacement therapy. J Endocrinol.2012;215(1):3-16.

42. Schwahn C, Polzer I, Haring R, Dörr M, Wallaschofski H, Kocher T, Mundt T, Hlotfreter B, Samietz S,Völzke H, Biffar R. Missing, unreplaced teeth and risk of all-cause and cardiovascular mortality. Int JCardiol. 2013;167(4):1430-7.

41. Haring R, Xanthakis V, Coviello A, Sullivan L, Wallaschofski H, Murabito JM, Vasan RS. Clinicalcorrelates of sex steroids and gonadotropins in men over the late adulthood: the Framingham HeartStudy. Int J Androl. 2012;35(6):775-82.

40. Ittermann T, Haring R, Wallaschofski H, Baumeister SE, Nauck M, Dörr M, Lerch MM, Meyer ZuSchwabedissen H, Rosskopf D, Völzke H. Inverse Association Between Serum Free Thyroxine Levels andHepatic Steatosis: Results from the Study of Health in Pomerania. Thyroid. 2012;22(6):568-74.

39. Haring R, Wallaschofski H. Talking testosterone: perspectives from a longitudinal population-basedcohort. BMJ. 2012;345:e5469

38. Haring R, Völzke H, Vasan RS, Felix SB, Nauck M, Dörr M, Wallaschofski H. Sex-Specific Associationsof Serum Prolactin Concentrations with Cardiac Remodeling: Longitudinal Results from the Study ofHealth Pomerania (SHIP). Atherosclerosis. 2012;221(2):570-6.

37. Hannemann A, Friedrich N, Spielhagen C, Nauck M,
Haring R. Young Adult Reference Ranges for Maleand Female Serum Sex Hormone Concentrations Measured on the Siemens ADVIA Centaur. J Lab Med.2012;36(1):9-16.

36. Haring R, Baumeister SE, Völzke H, Dörr M, Kocher T, Nauck M, Wallaschofski H. Prospective inverseassociations of sex hormone concentrations in men with biomarkers of inflammation and oxidativestress. J Androl. 2012;33(5):944-50.

35. Haring R, Wallaschofski H. Diving Through the ‘-omics’: The Case for Deep Phenotyping and SystemsEpidemiology. OMICS. 2012;16(5):231-4.

34. Haring R, Hannemann A, John U, Nauck M, Wallaschofski H, Keevil BG, Brabant G. Age-specificreference ranges for serum testosterone and androstenedione concentrations in women measured byliquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2012;97(2):408-15.

33. Empen K, Lorbeer R, Dörr M,Haring R, Nauck M, Gläser S, Krebs A, Reffelmann T, Ewert R, Völzke H,Wallaschofski H, Felix SB. Association of testosterone levels with endothelial function in men: resultsfrom a population-based study. Arterioscler Thromb Vasc Biol. 2012;32(2):481-6.

32. Friedrich N, Schneider HJ,Haring R, Nauck M, Völzke H, Kroemer H, Wallaschofski H. Improvedprediction of all-cause mortality by a combination of serum total testosterone and insulin-like growthfactor I in adult men. Steroids. 2012;77(1-2):52-8.

31. Ohlsson C, Wallaschofski H, Lunetta KL, Stolk L, Perry JR, Koster A, Petersen AK, Eriksson J,Lehtimäki T, Huhtaniemi IT, Hammond GL, Maggio M, Coviello AD; EMAS Study Group, Ferrucci L, HeierM, Hofman A, Holliday KL, Jansson JO, Kähönen M, Karasik D, Karlsson MK, Kiel DP, Liu Y, Ljunggren O,Lorentzon M, Lyytikäinen LP, Meitinger T, Mellström D, Melzer D, Miljkovic I, Nauck M, Nilsson M,Penninx B, Pye SR, Vasan RS, Reincke M, Rivadeneira F, Tajar A, Teumer A, Uitterlinden AG, Ulloor J,Viikari J, Völker U, Völzke H, Wichmann HE, Wu TS, Zhuang WV, Ziv E, Wu FC, Raitakari O, Eriksson A,Bidlingmaier M, Harris TB, Murray A, de Jong FH, Murabito JM, Bhasin S, Vandenput L, Haring R. Geneticdeterminants of serum testosterone concentrations in men. PLoS Genet. 2011;7(10):e1002313.

30. Haring R, Ernst F, Völker U, Schurmann C, Homuth G, Völzke H, Nauck M, Wallaschofski H. Theandrogen receptor CAG repeat polymorphism as a risk factor of low serum testosterone and itscardiometabolic effects in men. Int J Androl. 2012;35(4):511-20.

29. Haring R, Travison TG, Bhasin S, Vasan RS, Wallaschofski H, Davda MN, Coviello A, Murabito JM.Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachialindex: Findings from the Framingham Heart Study. J Clin Endocrinol Metab. 2011;96(12):3724-32.

28. Haring R, Feng YS, Moock J, Völzke H, Dörr M, Nauck M, Wallaschofski H, Kohlmann T. Self-perceived Quality of Life Predicts Mortality Risk Better than a Panel of Biomarkers, but the Combinationof Both Does Best. BMC Med Res Methodol. 2011;11(1):103.

27. Friedrich N, Schneider HJ, Spielhagen C, Markus MRP, Haring R, Grabe HJ, Buchfelder M,Wallaschofski H, Nauck M. The association of serum prolactin concentration with inflammatorybiomarkers – Cross-sectional findings from the population-based Study of Health in Pomerania. ClinEndocrinol. 2011;75(4):561-6.

26. Suhre K, Wallaschofski H, Raffler J, Friedrich F, Haring R, Michael K, Wasner C, Gieger C, KronenbergF, Chang D, Hoffmann W, Völzke H, Völker U, Teumer A, Biffar R, Kocher T, Felix SB, Kroemer HK,Römisch-Margl W, Nauck M. A genome-wide association study of metabolic traits in human urine: a viewof the genetic basis of detoxification capacity, chronic kidney disease and hyper-beta-aminoisobutyricaciduria. Nat Genet. 2011;43(6):565-9.

25. Zhai G, Teumer A, Stolk L, Perry JRB, Vandenput L, Coviello AD, Koster A, Bandinelli S, Bell JT, BhasinS, Eriksson J, Eriksson A, Ernst F, Ferrucci L, Frayling TM, Glass D, Grundberg E, Haring R, Hedman AK,Hofman A, Kiel DP, Kroemer HK, Liu Y, Lunetta L, Lorentzon M, Mangino M, Melzer D, Miljkovic I,MuTHER consortium, Nica A, Penninx B, Vasan RS, Small KS, Soranzo N, Uitterlinden AG, Völzke H,Wilson S, Xi L, Zhuang WV, Harris T, Murabito JM, Ohlsson C, Murray A, Jong F, Spector TD,Wallaschofski H. Eight common genetic variants associated with serum DHEAS levels suggests a key rolein ageing mechanisms. PLoS Genet. 2011;7(4):e1002025.

24. Haring R, Spielhagen C, Nauck M. Challenges in the measurement of serum testosteroneconcentrations as a biomarker of men’s health. J Lab Med. 2011;35(1):1-5.

23. Haring R, Nauck M, Völzke H, Endlich K, Lendeckel U, Friedrich N, Dörr M, Rettig R, Kroemer HK,Wallaschofski H. Low Serum Testosterone is Associated with Increased Mortality in Men With Stage 3 orGreater Nephropathy. Am J Nephrol. 2011;33(3):209-17.

22. Torkler S, Wallaschofski H, Baumeister SE, Völzke H, Dörr M, Felix S, Rettig R, Nauck M, Haring R.Inverse association between total testosterone concentrations, incident hypertension and bloodpressure. Aging Male. 2011;14:176-182.

21. Schipf S, Haring R, Friedrich N, Nauck M, Lau K, Alte D, Stang A, Völzke H, Wallaschofski H. Low totaltestosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results fromthe Study of Health in Pomerania (SHIP). Aging Male. 2011;14:168-175.

20. Koch B, Glaser S, Schaper C, Krebs A, Nauck M,
Haring R, Volzke H, Felix SB, Ewert R, WallaschofskiH, Friedrich N. Association Between Serum Testosterone and Sex Hormone Binding Globulin andExercise Capacity in Men: Results of the Study of Health in Pomerania (SHIP). J Androl. 2011;32(2):135-43.

19. Hannemann A, Friedrich N, Haring R, Krebs A, Völzke H, Alte D, Nauck M, Kohlmann T, Schober HC,Hoffmann W, Wallaschofski H. Thyroid function tests in patients taking thyroid medication in Germany:Results from the population-based Study of Health in Pomerania (SHIP). BMC Res Notes. 2010;3:227.

18. Haring R, Wallaschofski H, Nauck M, Felix SB, Schmidt CO, Dörr M, Sauer S, Wilmking G, Völzke H.Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to itscomponents. Exp Clin Endocrinol Diabetes. 2010;118(10):685-91.

17. Lau K, Lorbeer R, Haring R, Schmidt CO, Wallaschofski H, Nauck M, John U, Baumeister SE, Völzke H.The association between fatty liver disease and blood pressure in a population-based prospectivelongitudinal study. J Hypertens. 2010;28(9):1829-35.

16. Haring R, Baumeister SE, Völzke H, Dörr M, Felix SB, Kroemer HK, Nauck M, Wallaschofski H.Prospective association of low total testosterone concentrations with an adverse lipid profile andincreased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil. 2011;18:86-96.

15. Haring R, Ittermann T, Völzke H, Krebs A, Zygmunt M, Felix SB, Grabe HJ, Nauck M, Wallaschofski H.Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men:results from the study of health in Pomerania. Aging Male. 2010;13(4):247-57.

14. Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G,Havemann C, Ittermann T, Schipf S, Haring R, Baumeister SE, Wallaschofski H, Nauck M, Frick S, ArnoldA, Jünger M, Mayerle J, Kraft M, Lerch MM, Dörr M, Reffelmann T, Empen K, Felix SB, Obst A, Koch B,Gläser S, Ewert R, Fietze I, Penzel T, Dören M, Rathmann W, Haerting J, Hannemann M, Röpcke J,Schminke U, Jürgens C, Tost F, Rettig R, Kors JA, Ungerer S, Hegenscheid K, Kühn JP, Kühn J, Hosten N,Puls R, Henke J, Gloger O, Teumer A, Homuth G, Völker U, Schwahn C, Holtfreter B, Polzer I, KohlmannT, Grabe HJ, Rosskopf D, Kroemer HK, Kocher T, Biffar R, John U, Hoffmann W. Cohort Profile: The Studyof Health in Pomerania. Int J Epidemiol. 2011;40(2):294-307.

13. Haring R, Völzke H, Steveling A, Krebs A, Felix SB, Schöfl C, Dörr M, Nauck M, Wallaschofski H. Lowserum testosterone levels are associated with increased risk of mortality in a population-based cohort ofmen aged 20-79. Eur Heart J. 2010;31(12):1494-501.

12. Haring R, Baumeister SE, Völzke H, Kohlmann T, Marschall P, Flessa S, Nauck M, Wallaschofski H.Prospective association of low serum total testosterone levels with health care utilization and costs in apopulation-based cohort of men. Int J Androl. 2010;33(6):800-9.

11. Schipf S, Alte D, Völzke H, Friedrich N,
Haring R, Lohmann T, Rathmann W, Nauck M, Felix SB,Hoffmann W, John U, Wallaschofski H. Prevalence of metabolic syndrome in Germany: Results from theStudy of Health in Pomerania (SHIP). Diabetologie & Stoffwechsel. 2010;5(3):161-8.

10. Ittermann T, Haring R, Sauer S, Wallaschofski H, Dörr M, Nauck M, Völzke H. Decreased serum TSHlevels are not associated with mortality in the adult northeast German population. Eur J Endocrinol.2010;162(3):579-85.

9. Haring R, Wallaschofski H, Nauck M, Dörr M, Baumeister SE, Völzke H. Letter to the Editor, Authorreply: From liver markers to life expectancy. Hepatology. 2010;51(2):720-1.

8. van Noord C, Dörr M, Sturkenboom MC, Straus SM, Reffelmann T, Felix SB, Hofman A, Kors JA, HaringR, de Jong FH, Nauck M, Uitterlinden AG, Wallaschofski H, Witteman JC, Völzke H, Stricker BH. Theassociation of serum testosterone levels and ventricular repolarization. Eur J Epidemiol. 2010;25(1):21-8.

7. Völzke H, Haring R, Lorbeer R, Wallaschofski H, Reffelmann T, Empen K, Rettig R, John U, Felix SB,Dörr M. Heart valve sclerosis predicts all-cause and cardiovascular mortality. Atherosclerosis.2010;209(2):606-10.

6. Haring R, Wallaschofski H, Nauck M, Dörr M, Baumeister SE, Völzke H. Ultrasonographic hepaticsteatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidaselevels. Hepatology. 2009;50(5):1403-11.

5. Haring R, Völzke H, Felix SB, Schipf S, Dörr M, Rosskopf D, Nauck M, Schöfl C, Wallaschofski H.Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study ofhealth in Pomerania. Diabetes. 2009;58(9):2027-31.

4. Friedrich N, Haring R, Nauck M, Lüdemann J, Rosskopf D, Spilcke-Liss E, Felix SB, Dörr M, Brabant G,Völzke H, Wallaschofski H. Mortality and serum insulin-like growth factor (IGF)-I and IGF bindingprotein 3 concentrations. J Clin Endocrinol Metab. 2009;94(5):1732-9.

3. Haring R, Alte D, Völzke H, Sauer S, Wallaschofski H, John U, Schmidt CO. Extended recruitmentefforts minimize attrition but not necessarily bias. J Clin Epidemiol. 2009;62(3):252-60.

2. Völzke H, Haring R, Schmidt CO, Alte D, Kramer A, Hoffmann W, John U, Wallaschofski H. Doesresponse bias influence population studies of thyroid disorders? Thyroid. 2008;18(8):873-8.

1. Völzke H, Friedrich N, Schipf S, Haring R, Lüdemann J, Nauck M, Dörr M, Brabant G, Wallaschofski H.Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study. J Clin Endocrinol Metab. 2007;92(10):4039-45.

 

Herausgeber

Haring R. Kickbusch I, Ganten D, Moeti M. Handbook of Global Health. Springer New York. 2022; 2.917 S.ISBN 978-3-030-45008-3

Haring R. Gesundheitswissenschaften. Springer Reference Pflege – Therapie – Gesundheit. 2. Auflage.Springer-Verlag. 2022; 989 S. ISBN 978-3-662-58313-5

Haring R. Gesundheit digital – Perspektiven zur Digitalisierung der Medizin. Springer-Verlag. 2018; 233 S.ISBN 978-3-662-57610-6

Haring R.
, Siegmüller J. Evidenzbasierte Praxis in den Gesundheitsberufen – Chancen undHerausforderungen für Forschung und Anwendung. Springer-Verlag. 2017; 219 S. ISBN 978-3-662-55376-3

 

Bücher

Wilkening T, Haring R. Das Bio-Pizza Dilemma. Der überraschende Wegweiser zu mehr Nachhaltigkeit.Redline. 2021; 272 S. ISBN 3-868-81848-0. Absatz Erscheinungsjahr: 1.979 Exemplare.

Haring R, Wimmer J. Ein Schnupfen ist kein Beinbruch. Warum weniger Medizin oft gesünder ist. UllsteinVerlag. 2018; 248 S. ISBN 3-548-37712-2. Absatz Erscheinungsjahr: 10.689 Exemplare.
Spiegel-BestsellerKW5/2018

Haring R. Läuft bei mir!: Wie man auch ohne Erfolgsregeln entspannt Karriere macht. Redline. 2017; 128 S.ISBN 3-868-81675-5. Absatz Erscheinungsjahr: 401 Exemplare.

Wimmer J, Augustin M, Haring R. Alles über die Haut: Wie Sie gesund und natürlich schön bleiben.Ullstein Verlag. 2016; 208 S. ISBN 3-864-93044-7. Absatz Erscheinungsjahr: 10.162 Exemplare.
Spiegel-Bestseller KW23/2016

Haring R, Wimmer J. Fragen Sie Dr. Johannes: Ihr Weg zur besten Medizin. Ullstein Verlag. 2015; 240 S.ISBN 3-548-37620-7. Absatz Erscheinungsjahr: 5.456 Exemplare.

Haring R. Die Männerlüge: Wie viel Testosteron braucht der Mann? Braumüller Verlag. 2015; 192 S.
ISBN 3-991-00146-2. Absatz Erscheinungsjahr: 491 Exemplare.

Haring R. Der überforderte Patient: Gesund bleiben im Zeitalter der Hightech-Medizin. C.H.Beck. 2014;203 S. ISBN 3-406-66706-6. Absatz Erscheinungsjahr: 1.262 Exemplare.

 

Buchbeiträge und Kapitel

Kische H, Haring R. Geschlecht und Gesundheit – Grundlagen einer geschlechtssensiblen Medizin undGesundheitsvorsorge. In: Haring R. (Hrsg.) Gesundheitswissenschaften. Springer Reference Pflege –Therapie – Gesundheit. Springer-Verlag. 2021.

Haring R. Meta-Epidemiologie und Qualitätssicherung klinischer Evidenzproduktion. In: EvidenzbasiertePraxis in den Gesundheitsberufen – Chancen und Herausforderungen für Forschung und Anwendung.Springer-Verlag. 2017; pp 49-64.

Fischer T, Dörr M, Haring R, Langanke M. Alarming symptoms of a paradigm shift? An approach to bridgethe gap between hypothetical ethics and the current status of Individualized Medicine research. In:Vollmann J et al. The Ethics of Personalised Medicine: Critical Perspectives. Ashgate. 2015; pp 25-40.

Haring R, Budde K, Wallaschofski H. The Application of Metabolomic Profiling for the IndividualizedTherapy of Androgen Deficiency Syndrome (ADS) in Male Adults. In: Genetics meets Metabolomics: fromExperiment to Systems Biology. Springer. 2012; pp 139-155.

#